ArticleFrontiers in molecular biosciences2026
Development and evaluation of a machine learning based risk prediction model for osteoporosis.
Article in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Osteoporosis is a systemic bone disease that can lead to decreased bone strength and increased susceptibility to fractures. This study aims to evaluate the level of cytokines and other common blood biomarkers, and establish a machine learning-based risk prediction model for osteoporosis patients. Methods: The clinical data of patients with osteoporosis who were hospitalized in the Seventh Medical Center of the Chinese People's Liberation Army General Hospital from January 2023 to September 2024 were retrospectively collected. 16 cytokines and other potential predictive variables were analyzed to determine the independent risk factors. Eleven machine learning models were established, and the performance of the models was evaluated using the ROC curve, the PR curve and the confusion matrix, and the optimal model was selected. SHAP to provide insights into the model's predictions and construct a visual representation of the prediction model. Results: A total of 187 patients were included, and 16 characteristics such as IL-8 were identified as risk characteristics. By comparing 11 different models, it was found that the Gradient Boost was the best model, with an AUC value of 0.91, an accuracy rate of 0.81, an F1 score of 0.80, and a relatively balanced specificity and sensitivity. And the SHAP value was used to reveal the direction and strength of each feature in predicting osteoporosis. Conclusion: This study successfully developed a risk prediction model based on 16 common variables, including IL-8, providing critical evidence for the early identification and prevention of osteoporosis patients, with potential clinical significance.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.